NCT04659291

Brief Summary

Obstructive sleep apnea syndrome (OSAS) is a common disorder with prevalence rates of at least 4% among the middle-aged male Caucasians and Hong Kong (HK) Chinese populations. It is characterized by repetitive episodes of upper airway obstruction, causing intermittent hypoxia, sleep fragmentation, disabling daytime sleepiness, impaired cognitive function and poor health status. OSAS patients are at increased risks of non-fatal and fatal cardiovascular morbidity and mortality including sudden death, in addition to being more prone to road traffic accidents. However, there is no long term follow up of patients with OSAS on the incidence of cardiovascular disease, compliance on the therapy and the impact of the quality of life. The study is aimed to carry out a prospective observational study assessing the role of OSAS as a possible cause of increased cardiovascular risk and cognitive decline.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
27mo left

Started Aug 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress72%
Aug 2020Aug 2028

Study Start

First participant enrolled

August 30, 2020

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

August 31, 2020

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 9, 2020

Completed
7.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 29, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 29, 2028

Last Updated

February 20, 2024

Status Verified

February 1, 2024

Enrollment Period

8 years

First QC Date

August 31, 2020

Last Update Submit

February 18, 2024

Conditions

Keywords

cognitive function

Outcome Measures

Primary Outcomes (1)

  • incidence of Cardiovascular disease

    5 years

Secondary Outcomes (2)

  • Change of Montreal Cognitive Assessment score (MoCA)

    5 years

  • Change of Epworth Sleepiness Score

    5 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive patients are recruited from the Respiratory Clinic at the Prince of Wales Hospital with clinical suspicion of sleep-disordered breathing. The Respiratory Clinic receives referral from hospital specialists and general practitioners. The clinical evaluation procedure includes an interview by a respiratory specialist followed by either an inpatient polysomnography or home polygraphic study according to the patients' clinical characteristics and preference in concordance of the guidelines from the American Academy of Sleep Medicine (AASM). Sleep records will be scored based on standardized criteria of AASM.

You may qualify if:

  • suspected obstructive sleep apnea syndrome
  • aged 18 or above
  • must be able to speak, read and understand Chinese or English
  • possess the ability to respond to questions and follow instructions.

You may not qualify if:

  • already treated sleep apnea,
  • a limited life expectancy due to illness unrelated to sleep apnea
  • human immunodeficiency virus (HIV),
  • advanced renal disease,
  • uncontrolled malignancies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chinese University of Hong

Hong Kong, Please Select, Hong Kong

RECRUITING

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 31, 2020

First Posted

December 9, 2020

Study Start

August 30, 2020

Primary Completion (Estimated)

August 29, 2028

Study Completion (Estimated)

August 29, 2028

Last Updated

February 20, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations